Cerus Corp. (CERS)

4.46
0.13 2.90
NASDAQ : Health Technology
Prev Close 4.34
Open 4.37
Day Low/High 4.33 / 4.53
52 Wk Low/High 3.95 / 6.88
Volume 1.39M
Avg Volume 856.70K
Exchange NASDAQ
Shares Outstanding 140.32M
Market Cap 600.58M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Cerus Corporation Announces Third Quarter 2019 Results

Cerus Corporation Announces Third Quarter 2019 Results

Cerus Corporation (Nasdaq: CERS) today announced financial results for the third quarter ended September 30, 2019.

Cerus Corporation To Release Third Quarter 2019 Results And To Discuss Recent FDA Guidance For Bacterial Safety Of Platelets On October 30, 2019

Cerus Corporation To Release Third Quarter 2019 Results And To Discuss Recent FDA Guidance For Bacterial Safety Of Platelets On October 30, 2019

Cerus Corporation (Nasdaq:CERS) announced today that its third quarter 2019 results will be released on Wednesday, October 30, 2019, after the close of the stock market.

Cerus Corporation Announces Schedule Of Presentations At The 2019 AABB Annual Meeting

Cerus Corporation Announces Schedule Of Presentations At The 2019 AABB Annual Meeting

Cerus Corporation (Nasdaq:CERS) announced today its schedule of key events and presentations at the 2019 AABB Annual Meeting which is taking place in San Antonio, Texas on October 19 th through October 22 nd.

Relative Strength Alert For Cerus

Relative Strength Alert For Cerus

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cerus Corporation Applauds The Publication Of The Final Guidance Document On Bacterial Safety Standards For Platelet Collection And Transfusion

Cerus Corporation Applauds The Publication Of The Final Guidance Document On Bacterial Safety Standards For Platelet Collection And Transfusion

Cerus Corporation (Nasdaq: CERS) applauds the publication of the FDA final guidance document titled Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for...

Cerus Corporation To Present At The 2019 Cantor Global Healthcare Conference

Cerus Corporation To Present At The 2019 Cantor Global Healthcare Conference

Cerus Corporation (Nasdaq: CERS) today announced that Kevin D. Green, Cerus' vice president, finance and chief financial officer will present and provide a corporate update at the 2019 Cantor Global Healthcare Conference in New York City on Wednesday,...

First Week Of May 2020 Options Trading For Cerus

First Week Of May 2020 Options Trading For Cerus

Investors in Cerus Corp. saw new options become available this week, for the May 2020 expiration.

Cerus Corporation To Participate In Upcoming Investor Conferences

Cerus Corporation To Participate In Upcoming Investor Conferences

Cerus Corporation (Nasdaq: CERS) today announced that the Company will participate in two upcoming investor conferences.

Cerus Corporation Announces Record Second Quarter 2019 Results

Cerus Corporation Announces Record Second Quarter 2019 Results

Cerus Corporation (Nasdaq: CERS) today announced financial results for the second quarter ended June 30, 2019.

CERS Crosses Below Key Moving Average Level

CERS Crosses Below Key Moving Average Level

In trading on Thursday, shares of Cerus Corp. crossed below their 200 day moving average of $5.74, changing hands as low as $5.69 per share.

Cerus Corporation To Release Second Quarter 2019 Results On August 1, 2019

Cerus Corporation To Release Second Quarter 2019 Results On August 1, 2019

Cerus Corporation (Nasdaq:CERS) announced today that its second quarter 2019 results will be released on Thursday, August 1, 2019, after the close of the stock market.

Cerus Corporation Announces Presentations Highlighting INTERCEPT Blood System At The 29th Regional Congress Of The ISBT

Cerus Corporation Announces Presentations Highlighting INTERCEPT Blood System At The 29th Regional Congress Of The ISBT

Cerus Corporation (Nasdaq:CERS) announced today that multiple abstracts featuring the INTERCEPT Blood System pathogen reduction technology, including four oral presentations, will be included in the scientific program at the 29 th regional congress of...

1220 Concord Avenue (Photo: Business Wire)

1220 Concord Avenue (Photo: Business Wire)

Cerus Corporation (Nasdaq:CERS) announced today a new corporate branding campaign building upon the Company's leadership position in helping to safeguard the world's blood supply and the planned relocation of its corporate offices to a new facility in...

Cerus Is Now Oversold (CERS)

Cerus Is Now Oversold (CERS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cerus' INTERCEPT Blood System Provides Alternative To Year-Round Babesia Testing In Latest FDA Guidance Document

Cerus' INTERCEPT Blood System Provides Alternative To Year-Round Babesia Testing In Latest FDA Guidance Document

Cerus Corporation (Nasdaq: CERS) today announced that the FDA has issued a final guidance document recommending protocols for reducing the risk of transfusion transmitted Babesiosis.

Cerus (CERS) Shares Cross Below 200 DMA

Cerus (CERS) Shares Cross Below 200 DMA

In trading on Wednesday, shares of Cerus Corp. crossed below their 200 day moving average of $6.31, changing hands as low as $5.14 per share.

Cerus Corporation Announces Record First Quarter 2019 Results

Cerus Corporation Announces Record First Quarter 2019 Results

Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2019.

Cerus Corporation To Release First Quarter 2019 Results On May 7, 2019

Cerus Corporation To Release First Quarter 2019 Results On May 7, 2019

Cerus Corporation (Nasdaq:CERS) announced today that its first quarter 2019 results will be released on Tuesday, May 7, 2019, after the close of the stock market.

Cerus Becomes Oversold (CERS)

Cerus Becomes Oversold (CERS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cerus Breaks Below 200-Day Moving Average - Notable For CERS

Cerus Breaks Below 200-Day Moving Average - Notable For CERS

In trading on Friday, shares of Cerus Corp. crossed below their 200 day moving average of $6.39, changing hands as low as $6.35 per share.

Cerus Corporation Strengthens Balance Sheet With An Expandable Debt Facility Of Up To $90 Million

Cerus Corporation Strengthens Balance Sheet With An Expandable Debt Facility Of Up To $90 Million

Cerus Corporation (Nasdaq: CERS) today announced the closing of a new debt facility with MidCap Financial (MidCap) which is expandable up to $90 million.

Cerus Corporation Announces Appointment Of Jami Nachtsheim To Board Of Directors

Cerus Corporation Announces Appointment Of Jami Nachtsheim To Board Of Directors

Cerus Corporation (Nasdaq: CERS) today announced the appointment of Jami Nachtsheim to its Board of Directors.

Cerus Corporation Announces Record Fourth Quarter And Full Year 2018 Results

Cerus Corporation Announces Record Fourth Quarter And Full Year 2018 Results

Cerus Corporation (Nasdaq: CERS) today announced complete financial results for the fourth quarter and year ended December 31, 2018.

Cerus To Participate In Upcoming Investor Conferences

Cerus To Participate In Upcoming Investor Conferences

Cerus Corporation (Nasdaq:CERS) announced today that the Company will participate in two upcoming investor conferences.

Bullish Two Hundred Day Moving Average Cross - CERS

Bullish Two Hundred Day Moving Average Cross - CERS

In trading on Wednesday, shares of Cerus Corp. crossed above their 200 day moving average of $6.40, changing hands as high as $6.42 per share.

Cerus To Release Fourth Quarter And Full Year 2018 Results On February 26, 2019

Cerus To Release Fourth Quarter And Full Year 2018 Results On February 26, 2019

Cerus Corporation (Nasdaq:CERS) announced today that its fourth quarter and full-year 2018 results will be released on Tuesday, February 26, 2019, after the close of the stock market.

Cerus Announces Preliminary Fourth Quarter And Full Year 2018 Product Revenue

Cerus Announces Preliminary Fourth Quarter And Full Year 2018 Product Revenue

Cerus Corporation (Nasdaq:CERS) today announced unaudited preliminary product revenue for the fourth quarter and full year 2018 and provided 2019 product revenue guidance.

William Moore Appointed As Cerus Corporation's Senior Vice President Of Manufacturing Operations And Supply Chain

William Moore Appointed As Cerus Corporation's Senior Vice President Of Manufacturing Operations And Supply Chain

Cerus Corporation (Nasdaq:CERS) announced today the appointment of William Moore to the newly created position of Senior Vice President of Manufacturing Operations and Supply Chain for Cerus, effective January 1, 2019.

TheStreet Quant Rating: D- (Sell)